|
|
.
See Category: Neoplasms
ICD-10 (CM) Code and Descriptor
|
C16.1 |
Malignant neoplasm of fundus of stomach
|
C161 utilizaton on OPPS claims.*
Primary
ICD10 Code |
ICD10
Position 2 |
ICD10
Position 3 |
ICD10
Position 4 |
ICD10
Position 5 |
ICD10
Position 6 |
ICD10
Position 7 |
ICD10
Position 8 |
ICD10
Position 9 |
ICD10
Position 10 |
| 56.13%
|
26.19%
|
8.75%
|
3.73%
|
1.74%
|
1.06%
|
0.61%
|
0.69%
|
0.40%
|
0.26%
|
* Medicare Part A utilization data is derived from the 100% 2023 Outpatient (Fee-for-Service) Standard Analytical File.
Commonly Associated Procedure Codes for C16.1*:
| CPT |
Description |
Number of Claims |
Sum Performed |
|
85025
|
COMPLETE CBC W/AUTO DIFF WBC |
668
|
669
|
|
80053
|
COMPREHEN METABOLIC PANEL |
663
|
663
|
|
G0463
|
HOSPITAL OUTPT CLINIC VISIT |
537
|
544
|
|
36415
|
COLL VENOUS BLD VENIPUNCTURE |
365
|
367
|
|
J1642
|
INJ HEPARIN SODIUM PER 10 U |
214
|
10,499
|
|
96413
|
CHEMO IV INFUSION 1 HR |
203
|
203
|
|
Q9967
|
LOCM 300-399MG/ML IODINE,1ML |
202
|
19,214
|
|
74177
|
CT ABD & PELVIS W/CONTRAST |
180
|
180
|
|
71260
|
CT THORAX DX C+ |
177
|
177
|
|
82378
|
CARCINOEMBRYONIC ANTIGEN |
174
|
174
|
|
96372
|
THER/PROPH/DIAG INJ SC/IM |
161
|
162
|
|
96375
|
TX/PRO/DX INJ NEW DRUG ADDON |
158
|
261
|
|
J7030
|
NORMAL SALINE SOLUTION INFUS |
157
|
163
|
|
A9552
|
F18 FDG |
156
|
156
|
|
J9190
|
FLUOROURACIL INJECTION |
152
|
1,001
|
|
36591
|
DRAW BLOOD OFF VENOUS DEVICE |
151
|
151
|
|
78815
|
PET IMAGE W/CT SKULL-THIGH |
148
|
148
|
|
83735
|
ASSAY OF MAGNESIUM |
144
|
146
|
|
J1100
|
DEXAMETHASONE SODIUM PHOS |
135
|
1,722
|
|
J9263
|
OXALIPLATIN |
131
|
26,066
|
* Derived from 100% 2021 Outpatient (Fee-for-Service) Standard Analytical File.
C16.1 related to the following DRG Codes:
374-376
|
